Skip to content
Co-Diagnostics Inc icon

Co-Diagnostics Inc

CODXStocksBiotechnologyUnited StatesNasdaqUSD

Price

$1.25

Today

+11.6%

YTD

-75.1%

About

Co-Diagnostics Inc is an American biotechnology company primarily involved in the development, manufacture, and sale of molecular diagnostics technology. Operating internationally, the firm focuses on providing simple, fast, and accurate diagnostic tests for a range of diseases, relying on cutting-edge technology for enhanced detection of genetic material. The firm was founded in 2013 and is based in Salt Lake City, Utah. The company’s range of Logix SmartTM kits are used to detect mycobacteria tuberculosis (MTB), Zika virus, ZDC, COVID-19, and SARS-CoV-2. The firm is also involved in the development of vector control solutions, creating diagnostic tests that can be used to test populations of mosquitos and other organisms known to act as vectors in the spread of infectious diseases. In addition, Co-Diagnostics Inc is involved in testing programmes in agriculture, primarily in the genetic enhancement of agricultural products to ensure safe but productive crops worldwide. As well as its Salt Lake City headquarters, the firm has a facility located in Gujarat, India. The CoSara Clinical Laboratories facility is situated within the Ambalal Sarabhai Foundation, with the intention to expand research and development and manufacturing activities, as well as offering clinical services. Co-Diagnostics Inc is listed on the NASDAQ under the ticker CODX. Consider adding CODX stock to your eToro watchlist.

Price chart
Closing price history for CODX (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.

Open positions

0

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-0.05
P/S (TTM)9.17
P/B (TTM)0.42
Market cap$8.19M
Cap tierMicro-cap
Industry avg P/E-2.18

Profitability

Gross margin-170.74%
EBIT margin-5857.07%
Net margin-3782.43%
ROE-174.77%
ROA-149.25%

Earnings & Revenue

Revenue (TTM)$517,103.00
Revenue growth (1Y)-9.2%
EPS (TTM)-$22.46
Free cash flow$-27.47M
Total debt$1.80M

Dividends & Risk

Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.57
Employees115
Next earnings16 Nov '26
Trade history

Closed trades

0

Realized return

+0.0%

No stored closed trades exist for this instrument yet.

Co-Diagnostics Inc (CODX) | Dirk Kuyken